- Home
- SBET vs CYTO Comparison
SBET vs CYTO Comparison
Compare SBET & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- CYTO
- Stock Information
- Founded
- SBET 1995
- CYTO 2003
- Country
- SBET United States
- CYTO Bermuda
- Employees
- SBET N/A
- CYTO N/A
- Industry
- SBET Computer Software: Prepackaged Software
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- CYTO Health Care
- Exchange
- SBET Nasdaq
- CYTO Nasdaq
- Market Cap
- SBET 2.3M
- CYTO 2.2M
- IPO Year
- SBET 1997
- CYTO N/A
- Fundamental
- Price
- SBET $0.68
- CYTO $0.46
- Analyst Decision
- SBET
- CYTO
- Analyst Count
- SBET 0
- CYTO 0
- Target Price
- SBET N/A
- CYTO N/A
- AVG Volume (30 Days)
- SBET 319.5K
- CYTO 106.0K
- Earning Date
- SBET 11-26-2024
- CYTO 09-24-2024
- Dividend Yield
- SBET N/A
- CYTO N/A
- EPS Growth
- SBET N/A
- CYTO N/A
- EPS
- SBET 1.86
- CYTO N/A
- Revenue
- SBET $1,945,422.00
- CYTO N/A
- Revenue This Year
- SBET N/A
- CYTO N/A
- Revenue Next Year
- SBET N/A
- CYTO N/A
- P/E Ratio
- SBET $0.40
- CYTO N/A
- Revenue Growth
- SBET 79.18
- CYTO N/A
- 52 Week Low
- SBET $0.43
- CYTO $0.40
- 52 Week High
- SBET $2.18
- CYTO $17.20
- Technical
- Relative Strength Index (RSI)
- SBET 48.27
- CYTO 35.16
- Support Level
- SBET $0.59
- CYTO $0.40
- Resistance Level
- SBET $1.09
- CYTO $0.62
- Average True Range (ATR)
- SBET 0.11
- CYTO 0.06
- MACD
- SBET -0.00
- CYTO 0.00
- Stochastic Oscillator
- SBET 24.58
- CYTO 25.18
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the Company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The Company has two operating segments: Affiliate Marketing Services-United States and Affiliate Marketing Services-International. The company generates the majority of the revenue earned from the Affiliate Marketing Services-International segment.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.